Cadila Healthcare gains on the bourses

19 Oct 2018 Evaluate

Cadila Healthcare is currently trading at Rs. 379.90, up by 2.60 points or 0.69% from its previous closing of Rs. 377.30 on the BSE.

The scrip opened at Rs. 377.00 and has touched a high and low of Rs. 379.90 and Rs. 373.60 respectively.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 515.00 on 02-Nov-2017 and a 52 week low of Rs. 332.85 on 16-Aug-2018.

Last one week high and low of the scrip stood at Rs. 387.50 and Rs. 373.60 respectively. The current market cap of the company is Rs. 38625.81 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.34% and 7.87% respectively.

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Colchicine Tablets USP (US RLD - ColcyrsTM), 0.6 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

This medication is used to prevent or treat attacks of gout (also called gouty arthritis). This condition is caused by high uric acid levels in the blood. An attack of gout occurs when uric acid causes inflammation (pain, redness, swelling, and heat) in a joint. The group now has 223 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

893.45 11.50 (1.30%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×